A nonlinear feedback model capturing different patterns of tolerance and rebound
- PMID: 17689227
- DOI: 10.1016/j.ejps.2007.06.001
A nonlinear feedback model capturing different patterns of tolerance and rebound
Abstract
The objectives of the present analysis are to disect a class of turnover feedback models that have proven to be flexible from a mechanistic and empirical point of view, for the characterization of the onset, intensity and duration of response. Specifically, this class of models is designed so that it has the following properties: (I) Stimulation of the production term, which raises the steady state R(ss), causes an overshoot and a rebound upon return to baseline. (II) Stimulation of the loss term, which lowers the steady state R(ss), causes an overshoot which is negligible vis-a-vis the rebound upon the return to baseline. (III) Inhibition of the loss term, which raises the steady state R(ss), causes an overshoot which is larger than the rebound upon the return to the baseline. These models are then anchored in three datasets corresponding to the cases (I), (II) and (III). The objectives of this paper are to analyze the behavior of these turnover models from a mathematical/analytical point of view and to make simulations with different parameter settings and dosing regimens in order to highlight the intrinsic behavior of these models and draw some general conclusions. We also expand the analysis with two different extensions of the basic feedback model: one with a transduction step in the moderator and one which captures nonlinear phenomena (triggering mechanisms) caused by different drug input rates. A related objective is to come up with recommendations about experimental design and model building techniques in situations of feedback systems from a drug discovery point of view.
Similar articles
-
Quantitative analysis of rate and extent of tolerance of biomarkers: application to nicotinic acid-induced changes in non-esterified fatty acids in rats.Eur J Pharm Sci. 2011 Oct 9;44(3):250-64. doi: 10.1016/j.ejps.2011.08.005. Epub 2011 Aug 11. Eur J Pharm Sci. 2011. PMID: 21856416
-
A flexible nonlinear feedback system that captures diverse patterns of adaptation and rebound.AAPS J. 2008;10(1):70-83. doi: 10.1208/s12248-008-9007-x. Epub 2008 Feb 22. AAPS J. 2008. PMID: 18446507 Free PMC article. Review.
-
Mechanistic model of acute autoinhibitory feedback action after administration of SSRIs in rats: application to escitalopram-induced effects on brain serotonin levels.Eur J Pharm Sci. 2006 Dec;29(5):394-404. doi: 10.1016/j.ejps.2006.08.004. Epub 2006 Aug 12. Eur J Pharm Sci. 2006. PMID: 17014998
-
Pharmacokinetics and pharmacodynamics of amlodipine.Cardiology. 1992;80 Suppl 1:31-6. doi: 10.1159/000175050. Cardiology. 1992. PMID: 1534713
-
[Calcium channel blockers pharmacology and their use as tocolytics].J Gynecol Obstet Biol Reprod (Paris). 2015 Apr;44(4):305-11. doi: 10.1016/j.jgyn.2014.12.010. Epub 2015 Feb 26. J Gynecol Obstet Biol Reprod (Paris). 2015. PMID: 25728783 Review. French.
Cited by
-
Pattern Recognition in Pharmacodynamic Data Analysis.AAPS J. 2016 Jan;18(1):64-91. doi: 10.1208/s12248-015-9842-5. Epub 2015 Nov 5. AAPS J. 2016. PMID: 26542613 Free PMC article. Review.
-
Temporal linear mode complexity as a surrogate measure of the effect of remifentanil on the central nervous system in healthy volunteers.Br J Clin Pharmacol. 2011 Jun;71(6):871-85. doi: 10.1111/j.1365-2125.2011.03904.x. Br J Clin Pharmacol. 2011. PMID: 21223358 Free PMC article.
-
Delayed logistic indirect response models: realization of oscillating behavior.J Pharmacokinet Pharmacodyn. 2018 Feb;45(1):49-58. doi: 10.1007/s10928-017-9563-8. Epub 2018 Jan 8. J Pharmacokinet Pharmacodyn. 2018. PMID: 29313194
-
Modeling of free fatty acid dynamics: insulin and nicotinic acid resistance under acute and chronic treatments.J Pharmacokinet Pharmacodyn. 2017 Jun;44(3):203-222. doi: 10.1007/s10928-017-9512-6. Epub 2017 Feb 21. J Pharmacokinet Pharmacodyn. 2017. PMID: 28224315 Free PMC article.
-
Challenges of a mechanistic feedback model describing nicotinic acid-induced changes in non-esterified fatty acids in rats.J Pharmacokinet Pharmacodyn. 2013 Aug;40(4):497-512. doi: 10.1007/s10928-013-9325-1. Epub 2013 Jul 4. J Pharmacokinet Pharmacodyn. 2013. PMID: 23824920
MeSH terms
Substances
LinkOut - more resources
Full Text Sources